Compared to female breast cancer (FBC), MBC shows a higher prevalence of hormone receptor positivity and distinct germline predispositions, most frequently pathogenic variants in <i>BRCA2</i> and <i>CHEK2</i>. The gene discussed is NR4A1; the disease is breast carcinoma.